Healthcare provider profile · identity verified

Christopher A Steinmetz, MD

Internal Medicine · INDIANAPOLIS, IN · NPI 1750333928

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	976	286
Amlodipine Besylate	Amlodipine Besylate	629	200
Gabapentin	Gabapentin	469	115
Albuterol Sulfate Hfa	Albuterol Sulfate	450	118
Lisinopril	Lisinopril	390	110
Losartan Potassium	Losartan Potassium	386	126
Metformin Hcl	Metformin Hcl	346	105
Hydrochlorothiazide	Hydrochlorothiazide	344	113
Ozempic	Semaglutide	305	53
Omeprazole	Omeprazole	292	82
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	280	37
Fluticasone Propionate	Fluticasone Propionate	267	89
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	267	36
Pantoprazole Sodium	Pantoprazole Sodium	256	77
Tamsulosin Hcl	Tamsulosin Hcl	238	64
Metoprolol Succinate	Metoprolol Succinate	231	68
Potassium Chloride	Potassium Chloride	196	53
Levothyroxine Sodium	Levothyroxine Sodium	187	52
Torsemide	Torsemide	167	49
Trazodone Hcl	Trazodone Hcl	165	45
Carvedilol	Carvedilol	160	48
Metoprolol Tartrate	Metoprolol Tartrate	152	45
Eliquis	Apixaban	148	39
Tramadol Hcl	Tramadol Hcl	145	29
Ventolin Hfa	Albuterol Sulfate	143	43
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	133	43
Duloxetine Hcl	Duloxetine Hcl	124	33
Jardiance	Empagliflozin	116	30
Sertraline Hcl	Sertraline Hcl	101	27
Furosemide	Furosemide	99	37
Trulicity	Dulaglutide	98	26
Ibuprofen	Ibuprofen	95	29
Metformin Hcl Er	Metformin Hcl	95	31
Tizanidine Hcl	Tizanidine Hcl	94	22
Alendronate Sodium	Alendronate Sodium	90	26
Chlorthalidone	Chlorthalidone	90	27
Montelukast Sodium	Montelukast Sodium	90	23
Spironolactone	Spironolactone	89	35
Hydrocortisone	Hydrocortisone	88	27
Pravastatin Sodium	Pravastatin Sodium	86	21
Allopurinol	Allopurinol	84	31
Hydroxyzine Hcl	Hydroxyzine Hcl	77	27
Xarelto	Rivaroxaban	75	13
Buspirone Hcl	Buspirone Hcl	74	20
Ondansetron Odt	Ondansetron	74	20
Fluoxetine Hcl	Fluoxetine Hcl	71	20
Diclofenac Sodium	Diclofenac Sodium	69	33
Meloxicam	Meloxicam	63	12
Single Use Swab	Alcohol Antiseptic Pads	60	33
Incruse Ellipta	Umeclidinium Bromide	59	17
Rosuvastatin Calcium	Rosuvastatin Calcium	59	17
Warfarin Sodium	Warfarin Sodium	57	13
Clopidogrel	Clopidogrel Bisulfate	55	16
Esomeprazole Magnesium	Esomeprazole Magnesium	55	16
Escitalopram Oxalate	Escitalopram Oxalate	53	15
Spiriva Handihaler	Tiotropium Bromide	52	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	12
Colchicine	Colchicine	48	18
Symbicort	Budesonide/Formoterol Fumarate	47	17
Prednisone	Prednisone	44	30
Spiriva Respimat	Tiotropium Bromide	44	14
Famotidine	Famotidine	43	13
Naproxen	Naproxen	42	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	13
Ezetimibe	Ezetimibe	41	13
Oxycodone Hcl	Oxycodone Hcl	41	12
Breo Ellipta	Fluticasone/Vilanterol	40	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	40	13
Ketoconazole	Ketoconazole	38	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Peg 3350-Electrolyte	Sodium Chloride/Nahco3/Kcl/Peg	35	35
Hydralazine Hcl	Hydralazine Hcl	34	11
Topiramate	Topiramate	33	suppressed
Glipizide Er	Glipizide	32	13
Januvia	Sitagliptin Phosphate	32	11
Triamcinolone Acetonide	Triamcinolone Acetonide	32	18
Baclofen	Baclofen	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Finasteride	Finasteride	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Nitroglycerin	Nitroglycerin	27	14
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	26	11
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	18
Myrbetriq	Mirabegron	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Mupirocin	Mupirocin	20	11
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Felodipine Er	Felodipine	19	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	19	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Atenolol	Atenolol	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Simvastatin	Simvastatin	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Mounjaro	Tirzepatide	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Cephalexin	Cephalexin	15	13
Farxiga	Dapagliflozin Propanediol	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nystatin	Nystatin	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Gemtesa	Vibegron	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Diazepam	Diazepam	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Metformin Er Osmotic	Metformin Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error